Thomas Bachelot
Breast oncologist who led UNICANCER trials on brain metastases and hormone therapy resistance.
Thomas Bachelot led LANDSCAPE (lapatinib-capecitabine for brain metastases) and the TAMRAD and PADA-1 collaborations within UNICANCER's breast group.
Pages like this
not linked directly; found by shared links- TrialACE-Breast-02
Shares Lapatinib, HER2-positive breast cancer.
- PersonAnthony Gonçalves
Shares UNICANCER, HR-positive / HER2-negative breast cancer.
- PersonJean-Yves Blay
Shares Centre Léon Bérard, UNICANCER.
- PersonJame Abraham
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- PersonShinji Ohno
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- PersonClifford A. Hudis
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- PersonJonas Bergh
Shares HER2-positive breast cancer, HR-positive / HER2-negative breast cancer.
- InstitutionCentre Antoine Lacassagne
Shares UNICANCER, HR-positive / HER2-negative breast cancer.